ClinicalTrials.govpublic full text
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
nasopharyngeal carcinoma, radiotherapy, dose, pd-1, immune checkpoint inhibitor, capecitabine, quality of life, personalised therapy, complication, deintensification, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845838
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.